New and updated trials we’re tracking.
A 2026 study finds that L-theanine and lion’s mane mushrooms may ease stress, anxiety, and sleep issues in students — but the results are far more nuanced…
A clinical trial tests if psilocybin could help survivors of intimate partner violence heal from PTSD — and what it reveals about trauma and healing.
A Phase 2 trial is exploring whether psilocybin, the active compound in magic mushrooms, can make cognitive training more effective for older adults. This…
A Phase 2 trial testing psilocybin doses in treating severe alcohol use disorder.
A Phase 2 trial tests psilocybin’s impact on nicotine craving and brain activity.
A new study explores how psilocybin might reshape brain connections in treatment-resistant depression — and what it reveals about the mind’s hidden…
A small trial at Canada’s Centre for Addiction and Mental Health (CAMH) is investigating whether psilocybin, the active compound in magic mushrooms, could…
A clinical trial exploring psilocybin microdosing’s effects on mood, cognition, and brain imaging.
A groundbreaking trial explores whether combining psilocybin with trazodone could transform treatment-resistant depression — and what it reveals about the…
A groundbreaking trial is testing whether psilocybin can help athletes and others recover from lingering concussion symptoms — and the results could change…